bioRxiv : the preprint server for biology · 2025
Control of antigen presentation on MHC-I by a bacterial secretion system.
СтатьяПрепринтНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Leddy Owen, McGinn Rachel, Allsup Benjamin, Leone Madison, Timms Penny, Gutierrez-Gonzalez Matias, Fahad Ahmed S, Milligan Ryan, Garcia-Beltran Wilfredo F, DeKosky Brandon J, White Forest M, Bryson Bryan D
Аннотация
Mycobacterium tuberculosis (Mtb) remains one of the world's leading infectious killers. Although CD8 T cells contribute to immune control of tuberculosis, the pathways through which bacterial antigens access major histocompatibility complex class I (MHC-I) antigen presentation remain incompletely defined. Here, we show that the activity of an Mtb secretion system actively promotes antigen presentation on MHC-I. Using quantitative immunopeptidomics, host and bacterial genetic perturbations, and T cell activation assays, we demonstrate that presentation of Mtb-derived peptides on MHC-I requires the ESX-1 type VII secretion system. Presentation of these peptides proceeds in a manner dependent on the transporter associated with antigen processing (TAP) but independent of host cell mechanisms such as autophagy or MPEG1-mediated pore formation. Chemical induction of phagosomal membrane damage fails to restore antigen presentation in the absence of ESX-1 activity, suggesting that pathogen-encoded secretion, not nonspecific membrane rupture, governs access to MHC-I antigen processing pathways. These findings reveal a secretion system-driven mechanism of antigen presentation, redefining how mycobacteria interface with host MHC-I pathways, potentially informing tuberculosis vaccine design strategies, and highlighting a potential route for synthetic antigen delivery to the cytosol in therapeutics and vaccination.